Navigation Links
PharMEDium Introduces Innovative New Admixture Label Design
Date:6/9/2008

Initiative Designed to Enhance Recognition of Medication Name and Dose for

High-Alert, Error-Prone Compounded Preparations

SEATTLE, June 9 /PRNewswire/ -- PharMEDium Services, LLC, the leading provider of outsourced hospital pharmacy I.V. compounded solutions, has launched an enhanced labeling platform. The new design is intended to enhance quality of care in the OR while maximizing resources.

(Logo: http://www.newscom.com/cgi-bin/prnh/20051202/PHARMEDIUMLOGO)

The company announced the initiative at the American Society of Health-System Pharmacists' Summer Meeting and exhibition here.

The national initiative, the first of its kind in the outsourced compounding industry, was designed as a result of extensive research into current hospital labeling practices including a comprehensive failure and effects mode (FMEA) analysis around the overall readability of admixture labels and representation of critical drug information (e.g., drug name and concentration). This FMEA analysis led to the development of copyrighted, patent-pending warning statements that alert clinicians to appropriate dosing guidelines by drug category, said Rich Kruzynski, R.Ph., President, PharMEDium.

"The enhanced labeling platform aligns with the recommendations of national leaders involved in medication error-related quality and patient safety improvements, such as the Joint Commission," Kruzynski said. We are clearly taking strong steps to be part of the solution in improving resource utilization while supporting improvement in the quality of patient care."

The enhanced labeling will be implemented across all compounding services during 2008, Kruzynski said. Initially, the new labels will apply to four I.V. patient controlled analgesia (PCA) pain management drugs -- morphine, fentanyl, hydromorphone, and meperidine, as well as local anesthetics for epidural and peripheral nerve block therapy. "The platform will differentiate various PCA drugs in our service offering and doses within each drug family," he noted. "Upgraded I.V. PCA labels will first affect cassettes, syringes, and PCA vials. Over the remainder of 2008, we will be enhancing the labeling throughout our service platform."

About PharMEDium Services, LLC

For more than 15 years, PharMEDium has been the leading provider of outsourced compounding services. In that time, PharMEDium has grown into a nationwide network of state licensed and federally registered compounding centers providing trusted solutions to more than 1,800 hospitals throughout the United States. Managed by licensed pharmacists and staffed by certified technicians, the company complies with all applicable state laws and FDA regulations, including USP Chapter < 797 > and DEA requirements.

Contact: Amy Langan, MEDIA INQUIRIES: Jon Ross,

PharMEDium Director Ross Consulting &

of Marketing Communications

847/457-2327 773-271-0677

Email: info@pharmedium.com Email: jross1chi@prodigy.net


'/>"/>
SOURCE PharMEDium Services, LLC
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. PharMEDium Announces Availability of Pre-Filled Operating Room Perioperative Compounded Drugs
2. PharMEDium Announces Electronic 222 Ordering Initiative
3. PharMEDium Announces National Rollout of Electronic 222 Ordering Initiative
4. Delta Dental of Illinois Introduces Smile Smart For Your Health
5. Highmark Blue Cross Blue Shield Introduces New Health Plan Comparison Tool for Consumers
6. Highmark Blue Shield Introduces New Health Plan Comparison Tool for Consumers
7. Sentillion Introduces Affordable Next Generation Healthcare Single Sign-On Solution Called expreSSO(TM)
8. GladRags Introduces the Moon Cup - An Environmentally-Sound and Safe Alternative to Disposable Feminine Hygiene Products!
9. Triveris Introduces Personal Health Record with Built-in Health Advisor
10. Verizon Introduces Broadband Video Call Center Link for Deaf or Hard-of-Hearing Customers in Mid-Atlantic Region
11. Mecklenburg EMS Introduces Most-Advanced Situational Training in America for Emergency Medical Personnel
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/18/2017)... La. (PRWEB) , ... February 18, 2017 , ... ... released today provides the latest information and contact points to easily connect elderly ... home care, assisted living, and elder-care funding. It also conveys material on this ...
(Date:2/17/2017)... Murfreesboro, TN (PRWEB) , ... February 17, 2017 ... ... EHR mobility has not kept pace. Enovate Medical has introduced an innovative workstation ... 20 years of supporting nurses, the Encore Mobile EHR Workstation offers a lightweight, ...
(Date:2/17/2017)... FL (PRWEB) , ... February 17, 2017 , ... ... software tools that allow for the electronic prescribing of controlled and non-controlled substances ... , Ninety percent of pharmacies in the United States now accept electronic prescriptions, ...
(Date:2/17/2017)... Falls Church, VA (PRWEB) , ... ... ... to Integrate FDA Device Approval and Reimbursement , **An FDAnews Webinar**, Feb. ... , What are the critical reimbursement questions manufacturers should be asking ...
(Date:2/17/2017)... , ... February 17, 2017 , ... ... to Prevent a Warning Letter, **An FDAnews Webinar**, Feb. 23, 2017 — 1:30 ... manufacturers distinguish between corrective action (CA) and preventive action (PA)? , The methods ...
Breaking Medicine News(10 mins):
(Date:2/20/2017)... TOWN, South Africa , Feb. 20, 2017 /PRNewswire/ ... of illness and non-communicable diseases (NCDs) across sub-Saharan Africa, ... prescription drugs. The growing incidence of more Western lifestyle ... respiratory disease, in addition to infectious and parasitic illness, ... with a business opportunity of $40.8 billion ...
(Date:2/20/2017)... SAN FRANCISCO , February 20, 2017 /PRNewswire/ ... (CSF) management market  is anticipated to reach USD ... report by Grand View Research, Inc. Constant evaluation ... hydrocephalus management is expected to drive growth in ... the investment for development of novel and improved ...
(Date:2/20/2017)... 20, 2017 Acute, Chronic and Prophylaxis GVHD ... at a CAGR of 7% from 2016-2021 and CAGR of 3% from ... from 2016 to 2027. The market is estimated at $0.36bn in 2016, ... ... discover how you can exploit the future business opportunities emerging in this ...
Breaking Medicine Technology: